DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksClose Window
References
Takeuchi F, McGinnis R, Bourgeois S, Barnes C, Eriksson N, Soranzo N, Whittaker P, Ranganath V, Kumanduri V, McLaren W, Holm L, Lindh J, Rane A, Wadelius M, Deloukas P.
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose.
PLoS Genetics 2009;
05 (03) 1-9.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.